Eolo Pharma

Wilmington, DE · Founded 2017 · Privately Held (backing)

Developer of a pharmacological platform designed to treat obesity and its related chronic diseases through targeted small-molecule therapies. Eolo Pharma is based in Wilmington, DE and was founded in 2017. Its last reported valuation was $18 million in Sep 2022. It has raised $7.7 million.

Last reported valuation
$18.0M
Oct 2026
Priced at
—
Total raised
$7.7M
Last round
—

Who backs Eolo Pharma?

3 investors
InvestorType
Cites Startups—
Ficus Capital—
Securitas Biosciences Group—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Eolo Pharma investors

3 investors are on record for Eolo Pharma, including Cites Startups, Ficus Capital and Securitas Biosciences Group.

Free account
More of Eolo Pharma with a free account
  • ·Watch Eolo Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 3 firms already write checks for companies like Eolo Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View